Ovid pauses phase 2 plans for ROCK2 inhibitor to mull mixed data from Recursion's rival drug

0

13.11.2024 14:16

Fiercebiotech.com

Ovid pauses phase 2 plans for ROCK2 inhibitor to mull mixed data from Recursion's rival drug jwaldron Wed, 11/13/2024 - 06:16